Investing in Innovation (i3) program

The Investing in Innovation (i3) program is a $7 million pan‑African initiative supporting HealthTech and health supply‑chain startups. It aims to identify early‑stage and growth‑stage companies operating in Africa and provide them with grants, market access events and connections to a global healthcare ecosystem. Thirty companies per year will be selected by regional accelerators and become eligible for a systematic grant and continent‑wide market access support. The program is sponsored by partners including the Bill & Melinda Gates Foundation, AUDA‑NEPAD, WHO AFRO, Merck (MSD) and AmerisourceBergen.

Systematic grant of $50,000, market and government access events across Africa, and connection to a global healthcare ecosystem and partners.

Start-ups working in health product distribution and HealthTech companies operating in Africa are invited to apply.

Apply online via the program website innovationsinafrica.com